En español

NIDA/SAMHSA Blending Initiative

Revised August 2015

Blending Initiative logo

About the Blending Initiative:

Accelerating the dissemination of research-based drug abuse treatment into clinical practice is a priority for the National Institute on Drug Abuse (NIDA) and represents the core mission of the Blending Initiative. NIDA and the Substance Abuse and Mental Health Services Administration (SAMHSA) joined together to create the Blending Initiative in 2001 to reduce the gap that exists between the publication of research results and impact on treatment delivery. This initiative incorporates collaboration between clinicians, scientists, and experienced trainers to catalyze the creation of user-friendly treatment tools and products and facilitate the adoption of research-based interventions into front-line clinical settings. Through this initiative, NIDA and SAMHSA’s Addiction Technology Transfer Centers (ATTCs) disseminate treatment and training products based on results from studies conducted by the National Drug Abuse Clinical Trials Network (CTN) as well as other NIDA-supported research.  For additional information on the Blending Initiative, contact:
Kristen Huntley, Ph.D.

Blending Products:

Covers of Buprenorphine and HIV Testing products

Blending Meetings:

Additional information on Blending Products and other motivational incentive resources can be found at the Addiction Technology Transfer Center (ATTC) website

This page was last updated August 2015

Get this Publication

    National Drug Abuse Treatment Clinical Trials Network: Search listings of drug abuse clinical trials, click here
    SAMHSA Treatment Locator

    Talking to Patients about Health Risk Behaviors: Biew the CME/CE and Simulation